OKOxana O. Kiryukhina

Oxana O. Kiryukhina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Oxana O. Kiryukhina has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Pannexin 1 Knockout on Contraction of Mouse Mesenteric Arteries in Obstructive Cholestasis

    by O. O. Kiryukhina, M. G. Pechkova, O. S. Tarasova

    In liver disease, pannexin 1 (Panx1) expression in hepatic tissue increases, whereas genetic deletion of Panx1 appears to exert a protective effect against disease progression. This study aimed to explore the role of Panx1 in regulating mesenteric arterial tone in a mouse model of obstructive cholestasis (OC) induced by common bile duct ligation for three weeks. In wild-type mice, OC elevated Panx1 expression in mesenteric arteries, but contractile responses to an α1-adrenoceptor agonist and ATP remained unchanged. In contrast, mesenteric arteries from Panx1 knockout mice exhibited enhanced responses to both agonists under OC, along with increased NTPDase1 mRNA levels. These effects of OC in knockout animals may be associated with the activation of Panx1-independent pathways of ATP release from cells.

  • Bioinformatic and Behavioral Analysis of Pannexin 1 Involvement in Cutaneous Perception in Mice

    by O. O. Kiryukhina, O. S. Tarasova, Yu. V. Panchin

    To reveal new functions of pannexin 1 in the mouse nervous system, cell types with the most pronounced expression of the gene encoding this protein were identified by bioinformatic analysis. It turned out that sensory neurons PSNP3 and PSNP6 of the dorsal root ganglia have the highest expression levels of Panx1, as well as high expression of purinoreceptor p2rx3, and other genes associated with the perception of pain and skin itch. The scratch reflex induced by compound 48/80 was suppressed in Panx1 knockout mice compared to wild-type mice, confirming the involvement of Panx1 in the purinergic regulation of sensory nerve fibers responsible for itch perception.

  • The Study into the Role of Pannexin 1 in the Regulation of Contractile Activity of Longitudinal Smooth Muscle Layer in the Mouse Portal Vein

    by M. G. Pechkova, O. O. Kiryukhina, O. S. Tarasova

    Pannexin 1 is a protein capable of forming channels for the release of ATP from animal cells. In small arteries, it regulates the contraction of s

  • Open Access

    Исследование роли паннексина 1 в регуляции сократительной активности продольного гладкомышечного слоя портальной вены мыши

    by М. Г. Печкова, О. О. Кирюхина, О. С. Тарасова

    Паннексин 1 является белком, способным формировать каналы для выхода АТФ из клеток животных. В мелких артериях за счет функциональной связи с α1D-адренорецепторами он регулирует сокращение гладкомышечных клеток. Вены отличаются от артерий по строению и механизмам регуляции сокращения, но функции паннексина в венозном русле изучены мало. Цель работы заключалась в исследовании роли паннексина 1 в регуляции ритмической сократительной активности продольного гладкомышечного слоя портальной вены мыши. Сокращения изолированных продольных препаратов портальной вены, полученных от мышей с глобальным нокаутом гена Panx1 и С57Bl/6J (дикий тип), регистрировали в изометрических условиях. Препараты мышей обеих групп демонстрировали спонтанную ритмическую активность, однако частота сокращений у нокаутной группы была выше, чем у дикого типа. Агонисты α1-адренорецепторов фенилэфрин и метоксамин стимулировали сокращения вены, при этом эффект фенилэфрина, который обладает более высоким сродством к α1D-адренорецепторам, в нокаутной группе был ниже, тогда как эффект метоксамина не различался между группами. Экзогенный АТФ также вызывал увеличение частоты сокращений вены, причем у нокаутных по паннексину 1 мышей его эффект был менее выражен, чем у мышей дикого типа. Кроме того, у мышей дикого типа изменение частоты сокращений вены при действии фенилэфрина и АТФ (но не метоксамина) находилось в обратной зависимости от исходной частоты сокращений, у нокаутных мышей такой зависимости не наблюдалось. На фоне апиразы, разрушающей внеклеточный АТФ, влияние фенилэфрина на частоту сокращений вены становилось менее выраженным у мышей дикого типа, но не изменялось у нокаутных мышей. Таким образом, в портальной вене мыши паннексин 1 не принимает непосредственного участия в генерации миогенной ритмической активности, но может ее регулировать. Полученные результаты позволяют предположить, что в продольном гладкомышечном слое портальной вены мыши каналы паннексина 1 служат основным путем секреции АТФ, причем они функционально связаны с α1D-адренорецепторами.

  • Open Access

    Intrauterine L-NAME Exposure Weakens the Development of Sympathetic Innervation and Induces the Remodeling of Arterial Vessels in Two-Week-Old Rats

    by Ekaterina K. Selivanova, Anastasia A. Shvetsova, Anna A. Borzykh, Dina K. Gaynullina, Oxana O. Kiryukhina, Elena V. Lukoshkova, Viktoria M. Potekhina, Vladislav S. Kuzmin, Olga S. Tarasova

    Nitric oxide (NO) has been shown to stimulate differentiation and increase the survival of ganglionic sympathetic neurons. The proportion of neuronal NOS-immunoreactive sympathetic preganglionic neurons is particularly high in newborn rats and decreases with maturation. However, the role of NO in the development of vascular sympathetic innervation has never been studied before. We tested the hypothesis that intrauterine NO deficiency weakened the development of vascular sympathetic innervation and thereby changed the contractility of peripheral arteries and blood pressure level in two-week-old offspring. Pregnant rats consumed NOS inhibitor L-NAME (250 mg/L in drinking water) from gestational day 10 until delivery. Pups in the L-NAME group had a reduced body weight and blood level of NO metabolites at 1–2 postnatal days. Saphenous arteries from two-week-old L-NAME offspring demonstrated a lower density of sympathetic innervation, a smaller inner diameter, reduced maximal active force and decreased α-actin/β-actin mRNA expression ratio compared to the controls. Importantly, pups in the L-NAME group exhibited decreased blood pressure levels before, but not after, ganglionic blockade with chlorisondamine. In conclusion, intrauterine L-NAME exposure is followed by the impaired development of the sympathetic nervous system in early postnatal life, which is accompanied by the structural and functional remodeling of arterial blood vessels.


  • Open Access

    Intrauterine Nitric Oxide Deficiency Weakens Differentiation of Vascular Smooth Muscle in Newborn Rats

    by Anastasia A. Shvetsova, Anna A. Borzykh, Ekaterina K. Selivanova, Oxana O. Kiryukhina, Dina K. Gaynullina, Olga S. Tarasova

    Nitric oxide (NO) deficiency during pregnancy is a key reason for preeclampsia development. Besides its important vasomotor role, NO is shown to regulate the cell transcriptome. However, the role of NO in transcriptional regulation of developing smooth muscle has never been studied before. We hypothesized that in early ontogeny, NO is important for the regulation of arterial smooth muscle-specific genes expression. Pregnant rats consumed NO-synthase inhibitor L-NAME (500 mg/L in drinking water) from gestational day 10 till delivery, which led to an increase in blood pressure, a key manifestation of preeclampsia. L-NAME reduced blood concentrations of NO metabolites in dams and their newborn pups, as well as relaxations of pup aortic rings to acetylcholine. Using qPCR, we demonstrated reduced abundances of the smooth muscle-specific myosin heavy chain isoform, α-actin, SM22α, and L-type Ca2+-channel mRNAs in the aorta of newborn pups from the L-NAME group compared to control pups. To conclude, the intrauterine NO deficiency weakens gene expression specific for a contractile phenotype of arterial smooth muscle in newborn offspring.


  • Open Access

    Pannexin 1 Transgenic Mice: Human Diseases and Sleep-Wake Function Revision

    by Nariman Battulin, Vladimir M. Kovalzon, Alexey Korablev, Irina Serova, Oxana O. Kiryukhina, Marta G. Pechkova, Kirill A. Bogotskoy, Olga S. Tarasova, Yuri Panchin

    In humans and other vertebrates pannexin protein family was discovered by homology to invertebrate gap junction proteins. Several biological functions were attributed to three vertebrate pannexins members. Six clinically significant independent variants of the PANX1 gene lead to human infertility and oocyte development defects, and the Arg217His variant was associated with pronounced symptoms of primary ovarian failure, severe intellectual disability, sensorineural hearing loss, and kyphosis. At the same time, only mild phenotypes were observed in Panx1 knockout mice. In addition, a passenger mutation was identified in a popular line of Panx1 knockout mice, questioning even those effects. Using CRISPR/Cas9, we created a new line of Panx1 knockout mice and a new line of mice with the clinically significant Panx1 substitution (Arg217His). In both cases, we observed no significant changes in mouse size, weight, or fertility. In addition, we attempted to reproduce a previous study on sleep/wake and locomotor activity functions in Panx1 knockout mice and found that previously reported effects were probably not caused by the Panx1 knockout itself. We consider that the pathological role of Arg217His substitution in Panx1, and some Panx1 functions in general calls for a re-evaluation.


  • Open Access

    Endothelial function is impaired in conduit arteries of pannexin1 knockout mice

    by Dina Gaynullina, Olga S Tarasova, Oxana O Kiryukhina, Valery I Shestopalov, Yuri Panchin

    Pannexin1 is ubiquitously expressed in vertebrate tissues, but the role it plays in vascular tone regulation remains unclear. We found that Pannexin1 expression level is much higher in the endothelium relative to smooth muscle of saphenous artery. The ability of endothelium-intact arteries for dilation was significantly impaired whereas contractile responses were considerably increased in mice with genetic ablation of Pannexin1. No such increased contractile responses were detected in the endothelium-denuded arteries. Combined, our findings suggest a new function of Pannexin1 as an important player in normal endothelium-dependent regulation of arterial tone, where it facilitates vessel dilation and attenuates constriction.